Prof. Max Cryle is a Senior Research Fellow based in the Biomedicine Discovery Institute at Monash University. Since 2020, he is also a chief investigator in the ARC Centre of Excellence for Innovations in Peptide and Protein Science. After obtaining his PhD in chemistry from UQ in 2006, he moved to the Max Planck Institute for Medical Research in Heidelberg as a HFSP Cross Disciplinary Fellow. He was subsequently awarded funding from the German Research Foundation to establish his own group to investigate glycopeptide antibiotic biosynthesis as part of the Emmy Noether program: for this work, he was awarded the 2016 Otto Schmeil prize by the Heidelberg Academy of Arts and Sciences. In 2016, he joined EMBL Australia where his group investigates the biosynthesis of important peptide antibiotics together with novel strategies and targets for antimicrobial development. For this work he was recently awarded the Tregear Award from the Australian Peptide Society.